B
Bernhard Angermayr
Researcher at Medical University of Vienna
Publications - 31
Citations - 1545
Bernhard Angermayr is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Portal hypertension & Transjugular intrahepatic portosystemic shunt. The author has an hindex of 16, co-authored 31 publications receiving 1425 citations. Previous affiliations of Bernhard Angermayr include University of Vienna & University of Barcelona.
Papers
More filters
Journal ArticleDOI
Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt
Bernhard Angermayr,Manfred Cejna,F Karnel,Michael Gschwantler,Franz Koenig,Johann Pidlich,Helmuth Mendel,Ludwig Pichler,M. Wichlas,A. Kreil,M. Schmid,Arnulf Ferlitsch,E Lipinski,Harald Brunner,Johannes Lammer,Peter Ferenci,Alfred Gangl,Markus Peck-Radosavljevic +17 more
TL;DR: Although MELD was the primary predictor of overall survival in multivariate analysis, c statistics showed that both scores can be used for patients undergoing TIPS with equal accuracy, and there seems little reason to replace the well established Child-Pugh score.
Journal ArticleDOI
Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.
Mercedes Fernandez,Marc Mejias,Bernhard Angermayr,Juan Carlos García-Pagán,Juan Rodés,Jaime Bosch +5 more
TL;DR: It is demonstrated that the development of hyperdynamic splanchnic circulation and the formation of portal-systemic collateral vessels in portal hypertensive rats are angiogenesis-dependent processes that can be markedly inhibited by blockade of the VEGF signaling pathway.
Journal ArticleDOI
Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients
Valentin Fuhrmann,Nikolaus Kneidinger,Harald Herkner,Gottfried Heinz,Mariam Nikfardjam,Anja Bojic,Peter Schellongowski,Bernhard Angermayr,Reinhard Kitzberger,Joanna Warszawska,Ulrike Holzinger,Peter Schenk,C Madl +12 more
TL;DR: Hypoxic hepatitis is the consequence of multiorgan injury and outcome is influenced by the severity of liver impairment and the etiology and severity of the basic disease.
Journal ArticleDOI
Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents.
Bernhard Angermayr,Manfred Cejna,Franz Koenig,F Karnel,Franz Hackl,Alfred Gangl,Markus Peck-Radosavljevic +6 more
TL;DR: Patients undergoing ePTFE‐endoprosthesis implantation had higher survival rates within 2 years after TIPS‐implantation, which may be the result of improved patency rates after correct placement (up to the inferior caval vein [ICV]) of the eP TFE stentgraft.
Journal ArticleDOI
Impact of hypoxic hepatitis on mortality in the intensive care unit
Valentin Fuhrmann,Nikolaus Kneidinger,Harald Herkner,Gottfried Heinz,Mariam Nikfardjam,Anja Bojic,Peter Schellongowski,Bernhard Angermayr,Maximilian Schöniger-Hekele,C Madl,Peter Schenk +10 more
TL;DR: The presence of HH is a strong risk factor for mortality in the ICU in patients requiring vasopressor therapy, and it is demonstrated that HH occurs frequently in the medical ICU.